Search hospitals > Wisconsin > Green Bay

Green Bay Oncology Limited at Saint Mary's Hospital

Claim this profile
Green Bay, Wisconsin 54303
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Fallopian Tube Cancer
Conducts research for Breast cancer
260 reported clinical trials
4 medical researchers
Photo of Green Bay Oncology Limited at Saint Mary's Hospital in Green BayPhoto of Green Bay Oncology Limited at Saint Mary's Hospital in Green BayPhoto of Green Bay Oncology Limited at Saint Mary's Hospital in Green Bay

Summary

Green Bay Oncology Limited at Saint Mary's Hospital is a medical facility located in Green Bay, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Fallopian Tube Cancer, Breast cancer and other specialties. Green Bay Oncology Limited at Saint Mary's Hospital is involved with conducting 260 clinical trials across 316 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Jonathan E. Tammela.

Area of expertise

1Breast Cancer
Global Leader
Green Bay Oncology Limited at Saint Mary's Hospital has run 57 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive
2Lung Cancer
Global Leader
Green Bay Oncology Limited at Saint Mary's Hospital has run 39 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Top PIs

Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay2 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
53 reported clinical trials
120 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
31 reported clinical trials
85 drugs studied
Anthony J. JaslowskiSaint Vincent Hospital Cancer Center Green Bay6 years of reported clinical research
Studies Breast Cancer
Studies Cancer
27 reported clinical trials
49 drugs studied
Jonathan E. TammelaGreen Bay Oncology at Saint Vincent Hospital13 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
1 reported clinical trial
5 drugs studied

Clinical Trials running at Green Bay Oncology Limited at Saint Mary's Hospital

Lung Cancer
ALK Gene Rearrangement
Anaplastic Large Cell Lymphoma
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Green Bay Oncology Limited at Saint Mary's Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security